Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

NCT03245541 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Durvalumab
RADIATION: Stereotactic Ablative Body Radiotherapy (SABR)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]